To perform this study, stable GIPC-deficient pancreatic cancer cell lines were generated and the status of autophagy was monitored by assessing the expression of LC3-II, a protein that serves as a marker for autophagy. This evidence concerns the gene GIPC1 and familial pancreatic carcinoma.